2021
Second-Generation Antipsychotic Use in Pediatric Emergency Medicine.
Lambert C, Panagiotopoulos C, Davidson J, Goldman RD. Second-Generation Antipsychotic Use in Pediatric Emergency Medicine. Pediatric Emergency Care 2021, 37: 161-164. PMID: 33651760, DOI: 10.1097/pec.0000000000002387.Peer-Reviewed Original ResearchMeSH KeywordsAntipsychotic AgentsChildDiabetes Mellitus, Type 2HumansObesityPediatric Emergency MedicineWeight GainConceptsEmergency departmentSecond-generation antipsychotic prescriptionsPediatric emergency department providersPediatric emergency departmentEmergency department providersNumber of patientsType 2 diabetesGeneration antipsychotic useMental health complaintsRapid weight gainMental health conditionsPediatric emergency medicineCardiovascular complicationsMetabolic complicationsAntipsychotic prescriptionsGlucose intoleranceMetabolic syndromeCentral adiposityAntipsychotic usePrimary carePsychiatric servicesHealth complaintsWeight gainHealth conditionsSignificant risk
2018
Second-generation antipsychotics in children: Risks and monitoring needs.
Lambert C, Panagiotopoulos C, Davidson J, Goldman RD. Second-generation antipsychotics in children: Risks and monitoring needs. Canadian Family Physician 2018, 64: 660-662. PMID: 30209096, PMCID: PMC6135131.Peer-Reviewed Original ResearchMeSH KeywordsAntipsychotic AgentsChildDrug MonitoringGuideline AdherenceHumansMental DisordersMetabolic DiseasesPatient Acceptance of Health CareConceptsSide effectsSecond-generation antipsychotic treatmentSafety of antipsychoticsMetabolic side effectsSecond-generation antipsychoticsUse of SGAsEfficacy of treatmentPotential side effectsQuality of lifeAdjunctive metforminPediatric patientsMale patientsAntipsychotic treatmentFamily physiciansPhysical activityPatient's motherTherapeutic effortsHealthy eatingPatientsWeight gainSGAFamily practiceChildren guidelinesCanadian AlliancePotential role